Figure 2
Phase II trials: SVR rate with DAA in HCVG1 non responders. Blue, Triple combo with PI + PR. Yellow, QUAD with P+R. Green, interferon free combos.
Figure 2 | BMC Infectious Diseases
Phase II trials: SVR rate with DAA in HCVG1 non responders. Blue, Triple combo with PI + PR. Yellow, QUAD with P+R. Green, interferon free combos.